KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Halozyme Therapeutics (HALO) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for Halozyme Therapeutics (HALO) over the last 13 years, with Q4 2025 value amounting to 18.91.

  • Halozyme Therapeutics' Interest Coverage Ratio fell 14893.05% to 18.91 in Q4 2025 from the same period last year, while for Dec 2025 it was 25.87, marking a year-over-year decrease of 1509.97%. This contributed to the annual value of 25.87 for FY2025, which is 1509.97% down from last year.
  • Latest data reveals that Halozyme Therapeutics reported Interest Coverage Ratio of 18.91 as of Q4 2025, which was down 14893.05% from 50.73 recorded in Q3 2025.
  • Halozyme Therapeutics' Interest Coverage Ratio's 5-year high stood at 53.11 during Q2 2021, with a 5-year trough of 18.91 in Q4 2025.
  • Its 5-year average for Interest Coverage Ratio is 26.69, with a median of 25.87 in 2021.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first surged by 438426.38% in 2021, then tumbled by 14893.05% in 2025.
  • Quarter analysis of 5 years shows Halozyme Therapeutics' Interest Coverage Ratio stood at 27.51 in 2021, then tumbled by 40.74% to 16.3 in 2022, then increased by 18.72% to 19.36 in 2023, then soared by 99.72% to 38.66 in 2024, then tumbled by 148.93% to 18.91 in 2025.
  • Its Interest Coverage Ratio stands at 18.91 for Q4 2025, versus 50.73 for Q3 2025 and 46.07 for Q2 2025.